Cardiac Myoediting Attenuates Cardiac Abnormalities in Human and Mouse Models of Duchenne Muscular Dystrophy

Circ Res. 2021 Sep 3;129(6):602-616. doi: 10.1161/CIRCRESAHA.121.319579. Epub 2021 Aug 10.

Abstract

[Figure: see text].

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CRISPR-Cas Systems
  • Cardiomyopathies / etiology
  • Cardiomyopathies / therapy*
  • Cell Line
  • Cells, Cultured
  • Dependovirus / genetics
  • Dystrophin / genetics
  • Dystrophin / metabolism
  • Gene Editing / methods*
  • Genetic Therapy / methods*
  • Humans
  • Induced Pluripotent Stem Cells / cytology
  • Induced Pluripotent Stem Cells / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Muscular Dystrophy, Duchenne / complications
  • Muscular Dystrophy, Duchenne / therapy*
  • Myocytes, Cardiac / cytology
  • Myocytes, Cardiac / metabolism
  • Transcriptome

Substances

  • Dmd protein, mouse
  • Dystrophin